Delivery Order SPE2DB22D2206-SPE2DB23FKM40

Award Date 9/22/23
Potential Completion Date 9/25/23
Potential Value $4.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $3,546 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 1 mg vials of the drug remifentanil to the Defense Logistics Agency for use at its location in Conshohocken, Pennsylvania. The single-day period of performance spans August 10-11, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will serve as the prime contractor on the delivery...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,000 to Amerisourcebergen Drug Corporation to supply 1 mg vials of the drug remifentanil. Performance will take place in Conshohocken, Pennsylvania over a period of one day, from August 7th through August 8th, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No subcontractors or set aside designations were...
The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at $3,612.50 to provide 4561740719 units of the drug remifentanil hydrochloride in 1 mg vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in August 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen is well positioned to fulfill this small order for...
The Defense Logistics Agency awarded a $396,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1 million units of the drug remifentanil hydrochloride in 1 mg vials. The single award delivery order was issued against an existing Prime Vendor contract vehicle to supply pharmaceutical products and services to DLA and other Department of Defense customers. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania, with...
The Defense Logistics Agency awarded a $9,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation to supply 2 mg vials of the opioid analgesic remifentanil. Performance will take place in Conshohocken, Pennsylvania over a one-day period concluding on August 30, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will serve as the prime contractor in fulfilling the Defense Logistics Agency's requirement for this controlled pharmaceutical under an unstated...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $1,516.94. The order is for 4563132877 units of Remifentanil 1 mg vials to be delivered by December 19, 2023. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania. No set-aside designation was applied to this order, which was issued against an existing indefinite-delivery contract between Amerisourcebergen Drug...
Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for $7,063.30. The order is for the supply of 4563132319 units of Remifentanil 1 mg vials to support military treatment programs and facilities. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by December 19, 2023. No set-aside designation was applied to this order, which was issued against an...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 1 mg vials of the pharmaceutical drug remifentanil. The contract has a potential value of $4,770.38 and a completion date of January 8, 2024. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contracts from DLA to provide pharmaceuticals, medical supplies, and distribution services in support of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of REMIFENTANIL 1 MG VIALS. The order, valued at $1,063.41, has a completion date of March 8, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a for-profit organization that serves as a prime contractor providing pharmaceutical products and medical supplies to...
The Defense Logistics Agency awarded a $2,354 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562048946 units of 1 mg vials of remifentanil. The order is to be fulfilled by Amerisourcebergen's Conshohocken, Pennsylvania facility by September 6, 2023 in support of DLA programs. Remifentanil is an opioid analgesic for medical use as an anesthetic adjunct. This order was awarded under an existing DLA pharmaceutical supply vehicle and no set aside designation...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB23FKM40
    Delivery Order

The Defense Logistics Agency awarded a $4,389 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562290966 units of the drug remifentanil hydrochloride in 1 mg vials. As the prime contractor, Amerisourcebergen will deliver the ordered pharmaceutical products to a location in Conshohocken, Pennsylvania by September 25, 2023 to support the Defense Logistics Agency's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime without involvement of major subcontractors on this order issued under an existing DLA pharmaceuticals contract vehicle.

Generated 12/22/23, 11:01 AM